Vaccine to prevent breast cancer
Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
This phase I trial is designed to determine the maximum tolerated dose of the vaccine in patients with early-stage Triple Negative Breast Cancer and to characterize and optimize the body’s immune response.
Read more: https://lnkd.in/dn2d_96a
BIOMEDICA CRO is ready to collect high-quality human biospecimens to provide scientists with all needed samples and associated data for their preclinical studies. Please email us to start our collaboration: office@biomedica-cro.com or visit our page with relevant types of biospecimens.
